Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-09-29
1996-02-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514510, 514532, 514534, 514535, 514539, 514545, 514561, 514562, 514564, 514569, 514617, 514618, 514620, 514621, 514622, 514680, 514712, 514716, 514717, 514718, 514719, 514721, 514727, 514729, 514732, 560 10, 560 21, 560 23, 560 24, 560 25, 560 28, 560 52, 560 56, 560101, 560102, 564154, 564155, 564157, 564158, 564161, 564162, 564163, 564164, 564165, 564169, 564172, 568 31, 568 42, 568 43, 568 56, 568 58, 568306, 568326, 568585, 568586, 568632, 568633, 568634, 568659, 568660, 568661, 568662, 568705, 568808,
Patent
active
054929172
ABSTRACT:
Novel compounds of the general structural formula I: ##STR1## have endothelin antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, pulmonary hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, inflammatory diseases including Raynaud's disease and asthma.
REFERENCES:
Chemical Abstracts, vol. 108, No. 21925, Uno et al., 1987 "Preparation of 1-[Clarlang-and Sulfamoyl)alkyl]-1,4-diazacycloalkene derivatives as CA antagonists".
Nature, vol. 365, pp. 759-761, 21 Oct. 1993, by Martine Clozel, et al.
Proc. Natl. Acad. Sci. USA, vol. 91, pp. 8052-8056, Aug. 1994, Pharmacology, by E. H. Ohlstein, et al.
The Journal of Pharmacology and Experimental Therapeutics, vol. 271, No. 2, pp. 755-761, 1994, by P. Nambi, et al.
The Journal of Pharmacology and Experimental Therapeutics, vol.271, No. 2, pp. 762-768, 1994, by E. H. Ohlstein, et al.
The Journal of Pharmacology and Experimental Therapeutics, vol. 271, No. 2, pp. 769-775, 1994, by D. P. Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics, vol. 270, pp. 228-235, 1994, by M. Clozel, et al.
Chemical Abstract, vol. 100 (15) No. 138,708z, Fujiwara et al., 1989, "Studies on synthesis of 10,11-dihydro-5H-debenzy(a,a)cycloheptene derivatives".
Chemical Abstract vol. 91 (3) No. 20181s, Bicherov et al., "Tiberzotrophyin salts" 1979.
Rivero Ralph A.
Veber Daniel F.
Williams Peter D.
Camara Valerie J.
Covington Raymond
Daniel Mark R.
Ivy C. Warren
Merck & Co. , Inc.
LandOfFree
Endothelin antagonists incorporating a cyclobutane does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin antagonists incorporating a cyclobutane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonists incorporating a cyclobutane will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1356055